Bay Colony Advisors’s AstraZeneca AZN Stock Holding History

Bay Colony Advisors’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.49M	Sell	13,117 -21	-0.2%	-$3.95K	0.28%	75
2026 Q1	$2.59M	Buy	+13,138	New	+$2.53M	0.32%	63
2025 Q4	–	Sell	-12,798	Closed	-$1.96M	–	501
2025 Q3	$1.96M	Buy	12,798 +1,381	+12%	+$209K	0.23%	93
2025 Q2	$1.6M	Buy	11,417 +1,350	+13%	+$189K	0.22%	90
2025 Q1	$1.49M	Buy	10,067 +334	+3%	+$48.3K	0.23%	94
2024 Q4	$1.28M	Sell	9,733 -1,058	-10%	-$148K	0.19%	115
2024 Q3	$1.68M	Buy	10,791 +350	+3%	+$56.5K	0.25%	86
2024 Q2	$1.63M	Buy	10,441 +723	+7%	+$109K	0.27%	83
2024 Q1	$1.32M	Buy	9,718 +1,898	+24%	+$251K	0.23%	91
2023 Q4	$1.05M	Buy	7,820 +601	+8%	+$78.1K	0.21%	111
2023 Q3	$978K	Buy	7,219 +5,720	+382%	+$781K	0.24%	101
2023 Q2	$215K	Hold	1,499	–	–	0.05%	306
2023 Q1	$207K	Sell	1,499 -18	-1%	-$2.42K	0.05%	301
2022 Q4	$206K	Buy	+1,517	New	+$190K	0.05%	324
2022 Q3	–	Sell	-1,623	Closed	-$215K	–	327
2022 Q2	$215K	Sell	1,623 -347	-18%	-$45.5K	0.05%	303
2022 Q1	$261K	Buy	+1,970	New	+$236K	0.06%	290
2018 Q3	–	Sell	-35	Closed	-$2K	–	261
2018 Q2	$2K	Buy	+35	New	+$2.52K	﹤0.01%	851

Other funds holding AZN

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ZIC

ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return

CAM

Cidel Asset Management Toronto, Ontario, Ontario, Canada $2.08B AUM 24.89% 1-Year Est. Return

SAM

Sycomore Asset Management Paris, France $932M AUM 51.25% 1-Year Est. Return

PAS

Professional Advisory Services Vero Beach, Florida $836M AUM 25.79% 1-Year Est. Return

MIM

Martin Investment Management Palm Beach Gardens, Florida $300M AUM 6.05% 1-Year Est. Return

NONA

Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return

Bay Colony Advisors's AZN Position: Q2 2026 in Review

Bay Colony Advisors reduced its AstraZeneca (AZN) stake by 0.16% in Q2 2026, selling an estimated $3.95K and leaving 13,117 shares worth $2.49M. The position accounts for 0.28% of the portfolio, ranked #75.

Bay Colony Advisors first reported a position in AZN in Q2 2018 and has held it in 17 quarters since. The position peaked at $2.59M in Q1 2026. 233 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Bay Colony Advisors held 13,117 shares of AstraZeneca worth $2.49M as of Q2 2026.
Bay Colony Advisors sold 21 AstraZeneca shares in Q2 2026, an estimated $3.95K.
AstraZeneca made up 0.28% of Bay Colony Advisors's portfolio in Q2 2026, its #75 holding.
Bay Colony Advisors first reported a position in AstraZeneca in Q2 2018 and has held it in 17 quarters since.
Bay Colony Advisors's AstraZeneca position peaked at $2.59M in Q1 2026.
233 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Bay Colony Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.